New to The Street Renews Media Partnership With Acurx Pharma for Investor Outreach

New to The Street has renewed its multi-year media partnership with Acurx Pharmaceuticals, a clinical-stage biotech company developing next-generation antibiotics for difficult-to-treat infections. The expanded agreement continues a comprehensive campaign across television, digital platforms, and investor-focused events.

The collaboration includes national broadcasts on major financial networks, high-visibility billboard placements in New York City, and curated investor events, helping Acurx expand awareness among both retail and institutional audiences.

#NewToTheStreet
#AcurxPharmaceuticals
#Biotech
#Antibiotics
#InfectiousDisease
#InvestorRelations
#FinancialMedia
#HealthcareInnovation
#DrugDevelopment
#ClinicalTrials
#DigitalMarketing
#BrandAwareness
#Pharmaceuticals
#JaneKing
#NewsOut